InvestorsHub Logo
Followers 1041
Posts 116586
Boards Moderated 12
Alias Born 06/10/2006

Re: None

Monday, 10/27/2014 10:40:37 AM

Monday, October 27, 2014 10:40:37 AM

Post# of 55247
The Company’s business operations consist of doing business in the cell repair and cell replacement for Equine stock
at present, but we are pursuing FDA approval for existing and modified products to be used for the repair of the
Human Body. Its products have been successfully utilised for the repair of horses tendons and have the added bonus
of being patented in the name of the Company. In October 2013 we had to cease trialing the process due to lack of
available and sustainable funds.
The new initiative to generate investment into the company will allow us to
recommence these trials and move towards selling the product on the open market. As a result, the Company is still in
development and approval stage.
In February 2014 we appointed an IR company who are looking to raise the estimated $2million required to obtain
FDA approval of the patented process to make the product available to our targeted markets.



Anything said by me is strictly my opinion and is subject to change without notice. I am not a financial planner or advisor.